3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
28
Gastric Adenocarcinoma
4
Sarcopenia
2
Recurrence
1
Peritoneal Neoplasms
1
Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer
1
Osteoporosis
1
Obesity, Abdominal
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Margins of Excision
1
Locally Advanced Gastric Carcinoma
1
Locally Advanced Gastric Cancer
1
Hypertension
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Diabetes Mellitus
1
Coitus
1
Advanced Gastric Cancer
1
Adenocarcinoma
1
Interventions
Oxaliplatin
30
Gemcitabine
28
Fluorouracil
27
Capecitabine
22
Leucovorin
19
pembrolizumab
15
130-nm albumin-bound paclitaxel
13
Irinotecan
12
Cisplatin
11
Bevacizumab
11
Albumin-Bound Paclitaxel
11
Paclitaxel
10
Ramucirumab
8
Radiotherapy
8
Docetaxel
8
Nivolumab
7
trastuzumab deruxtecan
6
Cyclophosphamide
6
Taxes
5
Drug Therapy
5
durvalumab
4
Trastuzumab
4
Metformin
4
zolbetuximab
3
spartalizumab
3
folfirinox
3
cemiplimab
3
XELOX
3
Surgical Procedures, Operative
3
Sorafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Gastrectomy
×
Gastrointestinal
×
Clear all
NCT03013010
2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3
Completed
204 enrolled